New research suggests genetic testing at birth may hold the promise of detecting sudden infant death syndrome risk—and potentially other causes of sudden death later in life.
Using video evidence, researchers uncover a potential cause for sudden unexplained deaths in children, which usually occur during sleep.
The FDA has requested Philips conduct additional testing on its recalled CPAP, BiPAP, and ventilator devices, calling testing to date inadequate to fully evaluate the risks posed to users.
US Senator Dick Durbin and US Representative Jan Schakowsky have introduced legislation to reform medical device recalls in an effort to improve patient safety.
Read More
Sen. Richard Blumenthal is calling for “immediate, aggressive action” against Philips for keeping known defects with the company’s CPAP machines secret.
Read More
Philips Respironics says it plans to conduct additional testing on certain CPAP and respiratory devices involved in its June 2021 recall at the request of the FDA.
Read More
ProPublica and the Pittsburgh Post-Gazette have filed suit against the US Food and Drug Administration, accusing the agency of holding back records related to the recall of breathing machines.
Read More
A look at answers to some of the most critical questions about the ongoing recall of millions of CPAP machines, ventilators, and other breathing devices.
Read More
To understand the breakdowns that led to one of the most tumultuous medical device recalls in generations, ProPublica and the Pittsburgh Post-Gazette spent a year probing what happened inside Philips Respironics after the company first learned that contaminants were turning up in breathing machines designed to save lives.
Read More
Public health messages warning against infants sleeping with stuffed toys and blankets—contradicted by photos or videos circulating in movies and social media—don’t always find traction.
Read More
Philips Respironics provided the latest results and conclusions on the comprehensive test and research program to assess potential health risks related to the polyester-based polyurethane sound abatement foam in specific sleep therapy and ventilator devices under the voluntary June 2021 recall.
Read More
An initiative to solve a several thousand-year-old medical mystery—what causes sudden or unexplained infant deaths—has led to new insights that recently were presented at the 6th annual SIDS Summit.
Read More
Philips Respironics provided an update on the field action for specific sleep therapy and ventilator devices involved in the company’s ongoing recall.
Read More
The US Consumer Product Safety Commission is urging consumers to stop using infant loungers that were recalled in 2021, as well as other loungers that don’t meet sleep safety requirements.
Read More
The FDA updated its Philips Respironics recall safety communication to provide updated information about medical device reports that the agency received from Jan 1 to March 31.
Read More
Royal Philips’ CEO says the third-party risk assessments for the sleep therapy devices under the June 2021 recall are “positive and reassuring.”
Read More
Philips provides an update on field action for specific sleep therapy and ventilator devices involved in the company’s ongoing recall.
Read More
ECRI released its annual Top 10 Health Technology Hazards report, and its biggest safety concern directly relates to sleep medicine.
Read More